Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 57

1.

Towards standardized definitions for monitoring the continuum of HIV care in Europe.

Gourlay AJ, Pharris AM, Noori T, Supervie V, Rosinska M, van Sighem A, Touloumi G, Porter K.

AIDS. 2017 Sep 24;31(15):2053-2058. doi: 10.1097/QAD.0000000000001597. No abstract available.

2.

Autoimmune hepatitis and HIV infection: two case reports and review of the literature.

Zoboli F, Ripamonti D, Benatti SV, Comi L, Rizzi M.

AIDS. 2017 Sep 24;31(15):2172-2175. doi: 10.1097/QAD.0000000000001608. No abstract available.

PMID:
28906281
3.

The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.

Hyle EP, Jani IV, Rosettie KL, Wood R, Osher B, Resch S, Pei PP, Maggiore P, Freedberg KA, Peter T, Parker RA, Walensky RP.

AIDS. 2017 Sep 24;31(15):2135-2145. doi: 10.1097/QAD.0000000000001586.

4.

Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.

Lake AC.

AIDS. 2017 Sep 24;31(15):2115-2118. doi: 10.1097/QAD.0000000000001599.

PMID:
28906278
5.

Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Gianella S, Chaillon A, Mutlu EA, Engen PA, Voigt RM, Keshavarzian A, Losurdo J, Chakradeo P, Lada SM, Nakazawa M, Landay AL.

AIDS. 2017 Sep 24;31(15):2059-2067. doi: 10.1097/QAD.0000000000001579.

6.

Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients.

Fleury H, Tumiotto C, Bellecave P, Recordon-Pinson P.

AIDS Res Hum Retroviruses. 2018 Jan;34(1):27-30. doi: 10.1089/aid.2017.0175. Epub 2017 Oct 12.

PMID:
28899104
7.

A Summary of the Second Annual HIV Microbiome Workshop.

Williams B, Ghosh M, Boucher CAB, Bushman F, Carrington-Lawrence S, Collman RG, Dandekar S, Dang Q, Malaspina A, Paredes R, Wilson CC, Nowak P, Klatt NR, Lagenaur L, Landay AL.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1258-1264. doi: 10.1089/aid.2017.0137. Epub 2017 Oct 26.

PMID:
28899105
8.

High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy.

Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R.

AIDS Res Hum Retroviruses. 2017 Sep 13. [Epub ahead of print]

PMID:
28899162
9.

What Would an HIV Cure Mean to You? Qualitative Analysis from a Crowdsourcing Contest in Guangzhou, China.

Zhang A, Pan X, Wu F, Zhao Y, Hu F, Li L, Cai W, Tucker JD.

AIDS Res Hum Retroviruses. 2018 Jan;34(1):80-87. doi: 10.1089/AID.2017.0188. Epub 2017 Oct 12.

PMID:
28891318
10.

A 2-4-Amino Acid Deletion in the V5 Region of HIV-1 Env gp120 Confers Viral Resistance to the Broadly Neutralizing Human Monoclonal Antibody, VRC01.

Tachibana S, Sasaki M, Tanaka T, Inoue M, Ophinni Y, Kotaki T, Kameoka M.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1248-1257. doi: 10.1089/aid.2017.0063. Epub 2017 Oct 17.

PMID:
28903577
11.

Community Based Antiretroviral Treatment in Rural Zimbabwe.

Chimukangara B, Manasa J, Mitchell R, Nyabadza G, Katzenstein D, Masimirembwa C.

AIDS Res Hum Retroviruses. 2017 Dec;33(12):1185-1191. doi: 10.1089/aid.2017.0029. Epub 2017 Oct 26.

PMID:
28899102
12.

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.

Kattakuzhy S, Gross C, Emmanuel B, Teferi G, Jenkins V, Silk R, Akoth E, Thomas A, Ahmed C, Espinosa M, Price A, Rosenthal E, Tang L, Wilson E, Bentzen S, Masur H, Kottilil S; and the ASCEND Providers.

Ann Intern Med. 2017 Sep 5;167(5):311-318. doi: 10.7326/M17-0118. Epub 2017 Aug 8.

13.

Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.

Patel S, Leibrand CR, Palasuberniam P, Couraud PO, Weksler B, Jahr FM, McClay JL, Hauser KF, McRae M.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01307-17. doi: 10.1128/AAC.01307-17. Print 2017 Dec.

14.

Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.

Zhao N, Wang G, Das AT, Berkhout B.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01486-17. doi: 10.1128/AAC.01486-17. Print 2017 Dec.

15.

A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.

Kosaka M, Ushiki A, Ikuyama Y, Hirai K, Matsuo A, Hachiya T, Hanaoka M.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01173-17. doi: 10.1128/AAC.01173-17. Print 2017 Dec.

16.

Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline.

Siemieniuk RAC, Lytvyn L, Mah Ming J, Mullen RM, Anam F, Otieno T, Guyatt GH, Taylor GP, Beltrán-Arroyave C, Okwen PM, Nduati R, Kinuthia J, Luma HN, Kirpalani H, Merglen A, Lesi OA, Vandvik PO, Agoritsas T, Bewley S.

BMJ. 2017 Sep 11;358:j3961. doi: 10.1136/bmj.j3961. No abstract available.

17.

Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.

Macías J, Mancebo M, Merino D, Téllez F, Montes-Ramírez ML, Pulido F, Rivero-Juárez A, Raffo M, Pérez-Pérez M, Merchante N, Cotarelo M, Pineda JA; Spanish AIDS Research Network-HEP09 Study Group.

Clin Infect Dis. 2017 Sep 15;65(6):1012-1019. doi: 10.1093/cid/cix467.

PMID:
28903510
18.

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).

Trickey A, May MT, Schommers P, Tate J, Ingle SM, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, Monforte AD, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola D, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Clin Infect Dis. 2017 Sep 15;65(6):959-966. doi: 10.1093/cid/cix466.

19.

Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.

Fabbiani M, Muscatello A, Perseghin P, Bani M, Incontri A, Squillace N, Lapadula G, Gori A, Bandera A.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):219-224. doi: 10.1097/QAI.0000000000001480.

PMID:
28902679
20.

Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.

Smolders EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM.

J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):193-199. doi: 10.1097/QAI.0000000000001488.

PMID:
28902678

Supplemental Content

Support Center